| UniProt ID | ORC3_HUMAN | |
|---|---|---|
| UniProt AC | Q9UBD5 | |
| Protein Name | Origin recognition complex subunit 3 | |
| Gene Name | ORC3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 711 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Binds histone H3 and H4 trimethylation marks H3K9me3, H3K27me3 and H4K20me3.. | |
| Protein Sequence | MATSSMSKGCFVFKPNSKKRKISLPIEDYFNKGKNEPEDSKLRFETYQLIWQQMKSENERLQEELNKNLFDNLIEFLQKSHSGFQKNSRDLGGQIKLREIPTAALVLGVNVTDHDLTFGSLTEALQNNVTPYVVSLQAKDCPDMKHFLQKLISQLMDCCVDIKSKEEESVHVTQRKTHYSMDSLSSWYMTVTQKTDPKMLSKKRTTSSQWQSPPVVVILKDMESFATKVLQDFIIISSQHLHEFPLILIFGIATSPIIIHRLLPHAVSSLLCIELFQSLSCKEHLTTVLDKLLLTTQFPFKINEKVLQVLTNIFLYHDFSVQNFIKGLQLSLLEHFYSQPLSVLCCNLPEAKRRINFLSNNQCENIRRLPSFRRYVEKQASEKQVALLTNERYLKEETQLLLENLHVYHMNYFLVLRCLHKFTSSLPKYPLGRQIRELYCTCLEKNIWDSEEYASVLQLLRMLAKDELMTILEKCFKVFKSYCENHLGSTAKRIEEFLAQFQSLDETKEEEDASGSQPKGLQKTDLYHLQKSLLEMKELRRSKKQTKFEVLRENVVNFIDCLVREYLLPPETQPLHEVVYFSAAHALREHLNAAPRIALHTALNNPYYYLKNEALKSEEGCIPNIAPDICIAYKLHLECSRLINLVDWSEAFATVVTAAEKMDANSATSEEMNEIIHARFIRAVSELELLGFIKPTKQKTDHVARLTWGGC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 14 | Acetylation | SKGCFVFKPNSKKRK CCCEEEECCCCCCCE | 37.68 | 25953088 | |
| 20 | Ubiquitination | FKPNSKKRKISLPIE ECCCCCCCEEECCHH | 45.32 | 22817900 | |
| 21 | Acetylation | KPNSKKRKISLPIED CCCCCCCEEECCHHH | 45.59 | 7682003 | |
| 22 | Ubiquitination | PNSKKRKISLPIEDY CCCCCCEEECCHHHH | 6.25 | 22817900 | |
| 23 | Phosphorylation | NSKKRKISLPIEDYF CCCCCEEECCHHHHC | 31.00 | 25159151 | |
| 29 | Phosphorylation | ISLPIEDYFNKGKNE EECCHHHHCCCCCCC | 9.03 | - | |
| 32 | Ubiquitination | PIEDYFNKGKNEPED CHHHHCCCCCCCCCH | 62.45 | 21906983 | |
| 32 (in isoform 1) | Ubiquitination | - | 62.45 | 21890473 | |
| 32 (in isoform 2) | Ubiquitination | - | 62.45 | 21890473 | |
| 34 | Acetylation | EDYFNKGKNEPEDSK HHHCCCCCCCCCHHH | 60.80 | 7682013 | |
| 34 | Ubiquitination | EDYFNKGKNEPEDSK HHHCCCCCCCCCHHH | 60.80 | 22817900 | |
| 34 (in isoform 2) | Ubiquitination | - | 60.80 | - | |
| 41 | Acetylation | KNEPEDSKLRFETYQ CCCCCHHHHHHHHHH | 56.88 | 7682023 | |
| 41 | Ubiquitination | KNEPEDSKLRFETYQ CCCCCHHHHHHHHHH | 56.88 | 22817900 | |
| 41 (in isoform 1) | Ubiquitination | - | 56.88 | 21890473 | |
| 41 (in isoform 2) | Ubiquitination | - | 56.88 | 21890473 | |
| 46 | Phosphorylation | DSKLRFETYQLIWQQ HHHHHHHHHHHHHHH | 17.54 | 24719451 | |
| 47 | Phosphorylation | SKLRFETYQLIWQQM HHHHHHHHHHHHHHH | 8.30 | 24719451 | |
| 55 | Ubiquitination | QLIWQQMKSENERLQ HHHHHHHHHHHHHHH | 50.72 | 21906983 | |
| 55 (in isoform 1) | Ubiquitination | - | 50.72 | 21890473 | |
| 55 (in isoform 2) | Ubiquitination | - | 50.72 | 21890473 | |
| 56 | Phosphorylation | LIWQQMKSENERLQE HHHHHHHHHHHHHHH | 40.07 | 24719451 | |
| 86 | Ubiquitination | KSHSGFQKNSRDLGG HHCCCCCCCCCCCCC | 55.41 | 29967540 | |
| 88 | Phosphorylation | HSGFQKNSRDLGGQI CCCCCCCCCCCCCCE | 33.92 | 22985185 | |
| 96 | Ubiquitination | RDLGGQIKLREIPTA CCCCCCEEEEECCCC | 33.34 | 29967540 | |
| 110 | Ubiquitination | AALVLGVNVTDHDLT CEEEECCCCCCCCCC | 29.22 | 22817900 | |
| 112 | Ubiquitination | LVLGVNVTDHDLTFG EEECCCCCCCCCCHH | 23.55 | 22817900 | |
| 145 | Acetylation | AKDCPDMKHFLQKLI CCCCCCHHHHHHHHH | 38.29 | 23749302 | |
| 153 | Phosphorylation | HFLQKLISQLMDCCV HHHHHHHHHHHHHHH | 27.91 | 29083192 | |
| 163 | Ubiquitination | MDCCVDIKSKEEESV HHHHHHCCCCCCCCE | 51.52 | 22817900 | |
| 164 | Phosphorylation | DCCVDIKSKEEESVH HHHHHCCCCCCCCEE | 45.71 | 29083192 | |
| 165 | Ubiquitination | CCVDIKSKEEESVHV HHHHCCCCCCCCEEC | 65.23 | 22817900 | |
| 165 (in isoform 1) | Ubiquitination | - | 65.23 | 21890473 | |
| 165 (in isoform 2) | Ubiquitination | - | 65.23 | 21890473 | |
| 183 | Phosphorylation | KTHYSMDSLSSWYMT CCEECHHHHHHCEEE | 22.85 | 24275569 | |
| 185 | Phosphorylation | HYSMDSLSSWYMTVT EECHHHHHHCEEEEC | 23.83 | 24275569 | |
| 188 | Phosphorylation | MDSLSSWYMTVTQKT HHHHHHCEEEECCCC | 5.71 | 24275569 | |
| 198 | Ubiquitination | VTQKTDPKMLSKKRT ECCCCCHHHHCCCCC | 56.11 | 29967540 | |
| 205 | Phosphorylation | KMLSKKRTTSSQWQS HHHCCCCCCCCCCCC | 39.65 | 22199227 | |
| 206 | Phosphorylation | MLSKKRTTSSQWQSP HHCCCCCCCCCCCCC | 30.34 | 22199227 | |
| 207 | Phosphorylation | LSKKRTTSSQWQSPP HCCCCCCCCCCCCCC | 21.66 | 22199227 | |
| 208 | Phosphorylation | SKKRTTSSQWQSPPV CCCCCCCCCCCCCCE | 33.09 | 17525332 | |
| 212 | Phosphorylation | TTSSQWQSPPVVVIL CCCCCCCCCCEEEEE | 28.36 | 20068231 | |
| 235 | Ubiquitination | KVLQDFIIISSQHLH HHHHHHHHHCCCCHH | 2.23 | 22817900 | |
| 240 | Ubiquitination | FIIISSQHLHEFPLI HHHHCCCCHHCCCEE | 30.97 | 22817900 | |
| 285 | Ubiquitination | SLSCKEHLTTVLDKL CCCCHHHHHHHHHHH | 4.50 | 21890473 | |
| 287 | Ubiquitination | SCKEHLTTVLDKLLL CCHHHHHHHHHHHHH | 25.98 | 22817900 | |
| 292 | Ubiquitination | LTTVLDKLLLTTQFP HHHHHHHHHHHCCCC | 4.77 | 22817900 | |
| 325 | Ubiquitination | DFSVQNFIKGLQLSL CCCHHHHHHHHHHHH | 4.54 | 22817900 | |
| 330 | Ubiquitination | NFIKGLQLSLLEHFY HHHHHHHHHHHHHHH | 4.72 | 22817900 | |
| 337 | Ubiquitination | LSLLEHFYSQPLSVL HHHHHHHHCCCCCHH | 14.33 | 21890473 | |
| 340 | Ubiquitination | LEHFYSQPLSVLCCN HHHHHCCCCCHHHCC | 22.21 | 22817900 | |
| 345 | Ubiquitination | SQPLSVLCCNLPEAK CCCCCHHHCCCHHHH | 1.04 | 22817900 | |
| 365 | Ubiquitination | LSNNQCENIRRLPSF CCCCCCCHHHCCHHH | 40.47 | 29967540 | |
| 375 | Phosphorylation | RLPSFRRYVEKQASE CCHHHHHHHHHHCCH | 14.54 | - | |
| 375 | Ubiquitination | RLPSFRRYVEKQASE CCHHHHHHHHHHCCH | 14.54 | 21890473 | |
| 376 | Ubiquitination | LPSFRRYVEKQASEK CHHHHHHHHHHCCHH | 7.60 | 22817900 | |
| 378 | Ubiquitination | SFRRYVEKQASEKQV HHHHHHHHHCCHHHH | 40.91 | 22817900 | |
| 380 | Ubiquitination | RRYVEKQASEKQVAL HHHHHHHCCHHHHHH | 30.63 | 21890473 | |
| 383 | Acetylation | VEKQASEKQVALLTN HHHHCCHHHHHHHHC | 47.80 | 25953088 | |
| 383 | Ubiquitination | VEKQASEKQVALLTN HHHHCCHHHHHHHHC | 47.80 | 21906983 | |
| 383 (in isoform 1) | Ubiquitination | - | 47.80 | 21890473 | |
| 383 (in isoform 2) | Ubiquitination | - | 47.80 | 21890473 | |
| 388 | Ubiquitination | SEKQVALLTNERYLK CHHHHHHHHCHHHHH | 3.31 | 29967540 | |
| 390 | Ubiquitination | KQVALLTNERYLKEE HHHHHHHCHHHHHHH | 31.55 | 21890473 | |
| 394 | Ubiquitination | LLTNERYLKEETQLL HHHCHHHHHHHHHHH | 7.63 | 29967540 | |
| 404 | Ubiquitination | ETQLLLENLHVYHMN HHHHHHHHHCHHHHH | 35.10 | 27667366 | |
| 421 | Acetylation | LVLRCLHKFTSSLPK HHHHHHHHHHHCCCC | 37.07 | 25953088 | |
| 423 | Phosphorylation | LRCLHKFTSSLPKYP HHHHHHHHHCCCCCC | 23.39 | 20068231 | |
| 424 | Phosphorylation | RCLHKFTSSLPKYPL HHHHHHHHCCCCCCC | 32.77 | 20068231 | |
| 425 | Phosphorylation | CLHKFTSSLPKYPLG HHHHHHHCCCCCCCH | 45.71 | 20068231 | |
| 428 | Ubiquitination | KFTSSLPKYPLGRQI HHHHCCCCCCCHHHH | 65.87 | 21890473 | |
| 428 | Ubiquitination | KFTSSLPKYPLGRQI HHHHCCCCCCCHHHH | 65.87 | 22817900 | |
| 428 (in isoform 1) | Ubiquitination | - | 65.87 | 21890473 | |
| 428 (in isoform 2) | Ubiquitination | - | 65.87 | 21890473 | |
| 432 | Ubiquitination | SLPKYPLGRQIRELY CCCCCCCHHHHHHHH | 18.23 | 21890473 | |
| 456 | Ubiquitination | DSEEYASVLQLLRML CHHHHHHHHHHHHHH | 2.76 | 27667366 | |
| 466 | Ubiquitination | LLRMLAKDELMTILE HHHHHHHHHHHHHHH | 48.97 | 22817900 | |
| 467 | Ubiquitination | LRMLAKDELMTILEK HHHHHHHHHHHHHHH | 39.47 | 22817900 | |
| 468 | Ubiquitination | RMLAKDELMTILEKC HHHHHHHHHHHHHHH | 5.42 | 21963094 | |
| 470 | Ubiquitination | LAKDELMTILEKCFK HHHHHHHHHHHHHHH | 34.73 | 21890473 | |
| 471 | Ubiquitination | AKDELMTILEKCFKV HHHHHHHHHHHHHHH | 2.66 | 21890473 | |
| 473 | Ubiquitination | DELMTILEKCFKVFK HHHHHHHHHHHHHHH | 43.88 | 22817900 | |
| 480 | Acetylation | EKCFKVFKSYCENHL HHHHHHHHHHHHHCC | 43.43 | 26051181 | |
| 480 | Ubiquitination | EKCFKVFKSYCENHL HHHHHHHHHHHHHCC | 43.43 | 29967540 | |
| 481 | Ubiquitination | KCFKVFKSYCENHLG HHHHHHHHHHHHCCC | 24.45 | 22817900 | |
| 482 | Ubiquitination | CFKVFKSYCENHLGS HHHHHHHHHHHCCCH | 12.36 | 22817900 | |
| 485 | Ubiquitination | VFKSYCENHLGSTAK HHHHHHHHCCCHHHH | 31.93 | 21890473 | |
| 486 | Ubiquitination | FKSYCENHLGSTAKR HHHHHHHCCCHHHHH | 14.85 | 21890473 | |
| 492 | Ubiquitination | NHLGSTAKRIEEFLA HCCCHHHHHHHHHHH | 54.73 | - | |
| 492 (in isoform 2) | Ubiquitination | - | 54.73 | - | |
| 494 | Ubiquitination | LGSTAKRIEEFLAQF CCHHHHHHHHHHHHH | 6.15 | 27667366 | |
| 495 | Ubiquitination | GSTAKRIEEFLAQFQ CHHHHHHHHHHHHHH | 46.89 | 27667366 | |
| 503 | Phosphorylation | EFLAQFQSLDETKEE HHHHHHHCCCCCCCC | 38.79 | 23401153 | |
| 503 (in isoform 2) | Phosphorylation | - | 38.79 | - | |
| 507 | Phosphorylation | QFQSLDETKEEEDAS HHHCCCCCCCCCCCC | 43.34 | 28355574 | |
| 508 | Ubiquitination | FQSLDETKEEEDASG HHCCCCCCCCCCCCC | 62.17 | 29967540 | |
| 508 (in isoform 2) | Phosphorylation | - | 62.17 | - | |
| 509 | Ubiquitination | QSLDETKEEEDASGS HCCCCCCCCCCCCCC | 74.22 | 27667366 | |
| 510 | Ubiquitination | SLDETKEEEDASGSQ CCCCCCCCCCCCCCC | 63.83 | 27667366 | |
| 514 | Phosphorylation | TKEEEDASGSQPKGL CCCCCCCCCCCCCCC | 51.83 | 29523821 | |
| 515 (in isoform 2) | Phosphorylation | - | 31.83 | 26714015 | |
| 516 | Phosphorylation | EEEDASGSQPKGLQK CCCCCCCCCCCCCCH | 40.59 | 17525332 | |
| 517 (in isoform 2) | Phosphorylation | - | 47.45 | 26714015 | |
| 519 | Ubiquitination | DASGSQPKGLQKTDL CCCCCCCCCCCHHHH | 65.69 | 22817900 | |
| 520 | Ubiquitination | ASGSQPKGLQKTDLY CCCCCCCCCCHHHHH | 39.77 | 21963094 | |
| 523 | Ubiquitination | SQPKGLQKTDLYHLQ CCCCCCCHHHHHHHH | 49.39 | 21890473 | |
| 523 | Ubiquitination | SQPKGLQKTDLYHLQ CCCCCCCHHHHHHHH | 49.39 | 22817900 | |
| 523 (in isoform 1) | Ubiquitination | - | 49.39 | 21890473 | |
| 524 | Ubiquitination | QPKGLQKTDLYHLQK CCCCCCHHHHHHHHH | 20.48 | 21890473 | |
| 524 (in isoform 2) | Ubiquitination | - | 20.48 | 21890473 | |
| 525 | Ubiquitination | PKGLQKTDLYHLQKS CCCCCHHHHHHHHHH | 52.87 | 22817900 | |
| 527 | Phosphorylation | GLQKTDLYHLQKSLL CCCHHHHHHHHHHHH | 11.86 | 25159151 | |
| 531 | Ubiquitination | TDLYHLQKSLLEMKE HHHHHHHHHHHHHHH | 49.81 | 29967540 | |
| 532 | Phosphorylation | DLYHLQKSLLEMKEL HHHHHHHHHHHHHHH | 25.81 | 29214152 | |
| 532 | Ubiquitination | DLYHLQKSLLEMKEL HHHHHHHHHHHHHHH | 25.81 | 29967540 | |
| 532 (in isoform 2) | Ubiquitination | - | 25.81 | - | |
| 537 | Ubiquitination | QKSLLEMKELRRSKK HHHHHHHHHHHHCCC | 44.19 | 29967540 | |
| 538 | Ubiquitination | KSLLEMKELRRSKKQ HHHHHHHHHHHCCCC | 46.31 | 29967540 | |
| 543 | Acetylation | MKELRRSKKQTKFEV HHHHHHCCCCCHHHH | 47.27 | 7265723 | |
| 547 | Ubiquitination | RRSKKQTKFEVLREN HHCCCCCHHHHHHHH | 36.71 | 27667366 | |
| 548 | Ubiquitination | RSKKQTKFEVLRENV HCCCCCHHHHHHHHH | 9.97 | 27667366 | |
| 558 | Ubiquitination | LRENVVNFIDCLVRE HHHHHHHHHHHHHHH | 3.17 | 21963094 | |
| 559 | Ubiquitination | RENVVNFIDCLVREY HHHHHHHHHHHHHHH | 2.85 | 21963094 | |
| 561 | Glutathionylation | NVVNFIDCLVREYLL HHHHHHHHHHHHHCC | 3.02 | 22555962 | |
| 563 | Ubiquitination | VNFIDCLVREYLLPP HHHHHHHHHHHCCCC | 5.70 | 22817900 | |
| 564 | Ubiquitination | NFIDCLVREYLLPPE HHHHHHHHHHCCCCC | 17.56 | 22817900 | |
| 573 | Ubiquitination | YLLPPETQPLHEVVY HCCCCCCCCHHHHHH | 36.57 | 21963094 | |
| 574 | Ubiquitination | LLPPETQPLHEVVYF CCCCCCCCHHHHHHH | 43.00 | 21963094 | |
| 578 | Ubiquitination | ETQPLHEVVYFSAAH CCCCHHHHHHHHHHH | 2.70 | 22817900 | |
| 579 | Ubiquitination | TQPLHEVVYFSAAHA CCCHHHHHHHHHHHH | 3.48 | 22817900 | |
| 607 | Phosphorylation | HTALNNPYYYLKNEA HHHHCCHHHHHCHHH | 13.58 | 17360941 | |
| 611 | Ubiquitination | NNPYYYLKNEALKSE CCHHHHHCHHHHHCC | 36.30 | 21906983 | |
| 611 (in isoform 1) | Ubiquitination | - | 36.30 | 21890473 | |
| 612 | Ubiquitination | NPYYYLKNEALKSEE CHHHHHCHHHHHCCC | 36.86 | 21963094 | |
| 612 (in isoform 2) | Ubiquitination | - | 36.86 | 21890473 | |
| 616 | Ubiquitination | YLKNEALKSEEGCIP HHCHHHHHCCCCCCC | 63.97 | 22817900 | |
| 617 | Ubiquitination | LKNEALKSEEGCIPN HCHHHHHCCCCCCCC | 41.55 | 22817900 | |
| 617 (in isoform 2) | Ubiquitination | - | 41.55 | - | |
| 685 | Phosphorylation | ARFIRAVSELELLGF HHHHHHHHHHHHHCC | 35.16 | - | |
| 694 | Ubiquitination | LELLGFIKPTKQKTD HHHHCCCCCCCCCCC | 44.36 | 2190698 | |
| 694 (in isoform 1) | Ubiquitination | - | 44.36 | 21890473 | |
| 695 (in isoform 2) | Ubiquitination | - | 39.76 | 21890473 | |
| 699 | Ubiquitination | FIKPTKQKTDHVARL CCCCCCCCCCCCCCC | 58.43 | - | |
| 700 (in isoform 2) | Ubiquitination | - | 28.92 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ORC3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ORC3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ORC3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ORC2_HUMAN | ORC2 | physical | 12614612 | |
| ORC5_HUMAN | ORC5 | physical | 12614612 | |
| ORC6_HUMAN | ORC6 | physical | 12614612 | |
| MCM4_HUMAN | MCM4 | physical | 12614612 | |
| MCM7_HUMAN | MCM7 | physical | 12614612 | |
| ORC4_HUMAN | ORC4 | physical | 11395502 | |
| ORC5_HUMAN | ORC5 | physical | 11395502 | |
| BRCA1_HUMAN | BRCA1 | physical | 17525332 | |
| ORC2_HUMAN | ORC2 | physical | 10402192 | |
| ORC4_HUMAN | ORC4 | physical | 11323433 | |
| ORC6_HUMAN | ORC6 | physical | 11323433 | |
| ORC5_HUMAN | ORC5 | physical | 11323433 | |
| XRCC5_HUMAN | XRCC5 | physical | 15910003 | |
| XRCC6_HUMAN | XRCC6 | physical | 15910003 | |
| ORC2_HUMAN | ORC2 | physical | 15910003 | |
| ORC6_HUMAN | ORC6 | physical | 15910003 | |
| A4_HUMAN | APP | physical | 21832049 | |
| ORC5_HUMAN | ORC5 | physical | 22939629 | |
| ORC6_HUMAN | ORC6 | physical | 15232106 | |
| MCM7_HUMAN | MCM7 | physical | 15232106 | |
| ORC1_HUMAN | ORC1 | physical | 15232106 | |
| ORC4_HUMAN | ORC4 | physical | 15232106 | |
| ORC2_HUMAN | ORC2 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208 AND SER-516, ANDMASS SPECTROMETRY. | |